Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review

被引:13
作者
He, Yan-Fei [1 ]
Ouyang, Jing [2 ]
Hu, Xiao-Dong [3 ]
Wu, Ni [1 ]
Jiang, Zhi-Gang [4 ]
Bian, Ning [1 ]
Wang, Jie [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Hlth Management Ctr, Med Ctr 6, 6 Fu Cheng Rd, Beijing 100048, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Casualty Management Sect, Beijing 100048, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Endocrinol, Beijing 100048, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Hlth Management Ctr, Med Ctr 6, Beijing 100048, Peoples R China
关键词
COVID-19; Vaccination; Diabetes mellitus; Antibody; Blood glucose; Immune response; IMMUNE-RESPONSE; SEX-DIFFERENCES; OBESITY; IMMUNOGENICITY; TYPE-1; IMPACT; SAFETY; BLIND; RISK;
D O I
10.4239/wjd.v14.i6.892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDCoronavirus disease 2019 (COVID-19) is one of the current global public health threats and vaccination is the most effective tool to reduce the spread and decrease the severity of COVID-19. Diabetes is one of the important chronic diseases threatening human health and is a common comorbidity of COVID-19. What is the impact of diabetes on the immunization effect of COVID-19 vaccination? Conversely, does vaccination against COVID-19 exacerbate the severity of pre-existing diseases in patients with diabetes? There are limited and conflicting data on the interrelationship between diabetes and COVID-19 vaccination.AIMTo explore the clinical factors and possible mechanisms underlying the interaction between COVID-19 vaccination and diabetes.METHODSWe conducted a comprehensive search of PubMed, MEDLINE, EMBASE, and Reference Citation Analysis (https://www.referencecitationanalysis.com) online databases, and medRxiv and bioRxiv gray literature using the keywords "SARS-CoV-2", "COVID-19", "vaccine", "vaccination", "antibody", and "diabetes" individually or in combination, with a cut-off date of December 2, 2022. We followed inclusion and exclusion criteria and after excluding duplicate publications, studies with quantifiable evidence were included in the full-text review, plus three manually searched publications, resulting in 54 studies being included in this review.RESULTSA total of 54 studies were included, from 17 countries. There were no randomized controlled studies. The largest sample size was 350963. The youngest of the included samples was 5 years old and the oldest was 98 years old. The included population included the general population and also some special populations with pediatric diabetes, hemodialysis, solid organ transplantation, and autoimmune diseases. The earliest study began in November 2020. Thirty studies discussed the effect of diabetes on vaccination, with the majority indicating that diabetes reduces the response to COVID-19 vaccination. The other 24 studies were on the effect of vaccination on diabetes, which included 18 case reports/series. Most of the studies concluded that COVID-19 vaccination had a risk of causing elevated blood glucose. A total of 12 of the 54 included studies indicated a "no effect" relationship between diabetes and vaccination.CONCLUSIONThere is a complex relationship between vaccination and diabetes with a bidirectional effect. Vaccination may contribute to the risk of worsening blood glucose in diabetic patients and diabetic patients may have a lower antibody response after vaccination than the general population.
引用
收藏
页码:892 / 918
页数:27
相关论文
共 107 条
  • [81] Clinical Evaluation of Serum Levels of SARS-CoV-2 Anti-Spike Protein IgG Antibodies in Infected Patients and Vaccinated Subjects
    Santotoribio, Jose D.
    Franco-Garcia, Carmen
    Mondejar, Rufino
    Virto-Pena, Ianire
    Mayor-Reyes, Maria
    Garcia-Martin, Sofia
    Canavate-Solano, Consuelo
    Rodriguez-Garcia, Manuela
    Diez-Herran, Lourdes
    Cebada-Romero, Carmen
    de la Rubia-Martin, Francisca
    Jordan-Chaves, Juan
    Martinez-Rubio, Carmen
    Freyre-Carrillo, Carolina
    [J]. CLINICAL LABORATORY, 2022, 68 (07) : 1421 - 1427
  • [82] Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report
    Sasaki, Hironobu
    Itoh, Arata
    Watanabe, Yasuhiro
    Nakajima, Yuya
    Saisho, Yoshifumi
    Irie, Junichiro
    Meguro, Shu
    Itoh, Hiroshi
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (06) : 1105 - 1108
  • [83] New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report
    Sasaki, Keyaki
    Morioka, Tomoaki
    Okada, Natsumi
    Natsuki, Yuka
    Kakutani, Yoshinori
    Ochi, Akinobu
    Yamazaki, Yuko
    Shoji, Tetsuo
    Ohmura, Takashi
    Emoto, Masanori
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (07) : 1286 - 1289
  • [84] Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan
    Sato, Toshihiro
    Kodama, Shinjiro
    Kaneko, Keizo
    Imai, Junta
    Katagiri, Hideki
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (07) : 1518 - 1520
  • [85] Analysis of Factors Affecting Neutralizing Antibody Production after COVID-19 Vaccination Using Newly Developed Rapid Point-of-Care Test
    Shim, Hyeon Woo
    Shin, Jae hang
    Shin, Shang Cheol
    Lee, Hwa Jung
    So, Kyung Soon
    Lee, So Young
    Jun, Jae Woo
    Seo, Jeong Ku
    Lee, Hwa Seop
    Lee, Suk Young
    Kim, Seung Hyun
    Kim, Sun Jong
    Kim, Kyoung-Chol
    Ryu, Gyu Ha
    [J]. DIAGNOSTICS, 2022, 12 (08)
  • [86] Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
    Singh, Awadhesh Kumar
    Phatak, Sanjeev Ratnakar
    Singh, Ritu
    Bhattacharjee, Kingshuk
    Singh, Nagendra Kumar
    Gupta, Arvind
    Sharma, Arvind
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (02)
  • [87] Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study
    Singh, Awadhesh Kumar
    Phatak, Sanjeev Ratnakar
    Singh, Ritu
    Bhattacharjee, Kingshuk
    Singh, Nagendra Kumar
    Gupta, Arvind
    Sharma, Arvind
    [J]. VACCINE, 2021, 39 (44) : 6492 - 6509
  • [88] Diabetes in COVID-19: Prevalence, practical considerations
    Singh, Awadhesh Kumar
    Gupta, Ritesh
    Ghosh, Amerta
    Misra, Anoop
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 303 - 310
  • [89] Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study
    Sourij, Caren
    Tripolt, Norbert J.
    Aziz, Faisal
    Aberer, Felix
    Forstner, Patrick
    Obermayer, Anna M.
    Kojzar, Harald
    Kleinhappl, Barbara
    Pferschy, Peter N.
    Mader, Julia K.
    Cvirn, Gerhard
    Goswami, Nandu
    Wachsmuth, Nadine
    Eckstein, Max L.
    Mueller, Alexander
    Abbas, Farah
    Lenz, Jacqueline
    Steinberger, Michaela
    Knoll, Lisa
    Krause, Robert
    Stradner, Martin
    Schlenke, Peter
    Sareban, Nazanin
    Prietl, Barbara
    Kaser, Susanne
    Moser, Othmar
    Steinmetz, Ivo
    Sourij, Harald
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (05) : 849 - 858
  • [90] Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
    Stuart, Arabella S., V
    Shaw, Robert H.
    Liu, Xinxue
    Greenland, Melanie
    Aley, Parvinder K.
    Andrews, Nick J.
    Cameron, J. C.
    Charlton, Sue
    Clutterbuck, Elizabeth A.
    Collins, Andrea M.
    Darton, Tom
    Dinesh, Tanya
    Duncan, Christopher J. A.
    England, Anna
    Faust, Saul N.
    Ferreira, Daniela M.
    Finn, Adam
    Goodman, Anna L.
    Green, Christopher A.
    Hallis, Bassam
    Heath, Paul T.
    Hill, Helen
    Horsington, Bryn M.
    Lambe, Teresa
    Lazarus, Rajeka
    Libri, Vincenzo
    Lillie, Patrick J.
    Mujadidi, Yama F.
    Payne, Ruth
    Plested, Emma L.
    Provstgaard-Morys, Samuel
    Ramasamy, Maheshi N.
    Ramsay, Mary
    Read, Robert C.
    Robinson, Hannah
    Screaton, Gavin R.
    Singh, Nisha
    Turner, David P. J.
    Turner, Paul J.
    Vichos, Iason
    White, Rachel
    Nguyen-Van-Tam, Jonathan S.
    Snape, Matthew D.
    [J]. LANCET, 2022, 399 (10319) : 36 - 49